BioInnovation Institute (BII) is an international hub for research-based innovation and entrepreneurship and embraces every development phase of early-stage life science start-ups within biotech, pharma and medtech. In BII, projects have access to a vibrant life science community and 2,300 square meters of state-of-the-art lab and office facilities, business acceleration programs, start-up business incubation, commercial support, unique funding opportunities and access to high-level mentoring and international networks. For the first three years of operations, BII has been granted DKK 392 million by the Novo Nordisk Foundation to bring ideas to life and research to market. BII is located in Copenhagen Bio Science Park (COBIS) in Copenhagen, Denmark. Read more on the BII website.